z-logo
open-access-imgOpen Access
Regression of Hepatic Fibrosis and Evolution of Cirrhosis: A Concise Review
Author(s) -
Shahbaz Khan,
Romil Saxena
Publication year - 2021
Publication title -
advances in anatomic pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.606
H-Index - 76
eISSN - 1533-4031
pISSN - 1072-4109
DOI - 10.1097/pap.0000000000000312
Subject(s) - cirrhosis , medicine , fibrosis , hepatocellular carcinoma , hepatic fibrosis , pathology , population , gastroenterology , environmental health
Fibrosis is not a unidirectional, linear process, but a dynamic one resulting from an interplay of fibrogenesis and fibrolysis depending on the extent and severity of a biologic insult, or lack thereof. Regression of fibrosis has been documented best in patients treated with phlebotomies for hemochromatosis, and after successful suppression and eradication of chronic hepatitis B and C infections. This evidence mandates a reconsideration of the term "cirrhosis," which implies an inevitable progression towards liver failure. Furthermore, it also necessitates a staging system that acknowledges the bidirectional nature of evolution of fibrosis, and has the ability to predict if the disease process is progressing or regressing. The Beijing classification attempts to fill this gap in contemporary practice. It is based on microscopic features termed "the hepatic repair complex," defined originally by Wanless and colleagues. The elements of the hepatic repair complex represent the 3 processes of fragmentation and regression of scar, vascular remodeling (resolution), and parenchymal regeneration. However, regression of fibrosis does not imply resolution of cirrhosis, which is more than just a stage of fibrosis. So far, there is little to no evidence to suggest that large regions of parenchymal extinction can be repopulated by regenerating hepatocytes. Similarly, the vascular lesions of cirrhosis persist, and there is no evidence of complete return to normal microcirculation in cirrhotic livers. In addition, the risk of hepatocellular carcinoma is higher compared with the general population and these patients need continued screening and surveillance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here